BRPI0803650A2 - uso de glicosaminoglicanos para reduzir ligação não especìfica em imunoensaios - Google Patents
uso de glicosaminoglicanos para reduzir ligação não especìfica em imunoensaiosInfo
- Publication number
- BRPI0803650A2 BRPI0803650A2 BRPI0803650-0A BRPI0803650A BRPI0803650A2 BR PI0803650 A2 BRPI0803650 A2 BR PI0803650A2 BR PI0803650 A BRPI0803650 A BR PI0803650A BR PI0803650 A2 BRPI0803650 A2 BR PI0803650A2
- Authority
- BR
- Brazil
- Prior art keywords
- analyte
- glycosaminoglycan
- reduce nonspecific
- glycosaminoglycans
- immunoassays
- Prior art date
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 title abstract 6
- 230000009871 nonspecific binding Effects 0.000 title abstract 4
- 238000003018 immunoassay Methods 0.000 title abstract 3
- 239000012491 analyte Substances 0.000 abstract 7
- 239000011230 binding agent Substances 0.000 abstract 3
- 239000003153 chemical reaction reagent Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 abstract 1
- 229920001287 Chondroitin sulfate Polymers 0.000 abstract 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 229940059329 chondroitin sulfate Drugs 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 229920000669 heparin Polymers 0.000 abstract 1
- 229960002897 heparin Drugs 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Abstract
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/846,390 US8617820B2 (en) | 2007-08-28 | 2007-08-28 | Use of glycosaminoglycans to reduce non-specific binding in immunoassays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0803650A2 true BRPI0803650A2 (pt) | 2009-05-05 |
Family
ID=39967577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0803650-0A BRPI0803650A2 (pt) | 2007-08-28 | 2008-08-28 | uso de glicosaminoglicanos para reduzir ligação não especìfica em imunoensaios |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US8617820B2 (pt) |
| EP (1) | EP2031392B1 (pt) |
| JP (1) | JP5274934B2 (pt) |
| KR (1) | KR101557034B1 (pt) |
| CN (1) | CN101377488B (pt) |
| AR (1) | AR068043A1 (pt) |
| AU (1) | AU2008207454B2 (pt) |
| BR (1) | BRPI0803650A2 (pt) |
| CA (1) | CA2639196C (pt) |
| CL (1) | CL2008002525A1 (pt) |
| ES (1) | ES2525330T3 (pt) |
| RU (1) | RU2490648C2 (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012513586A (ja) * | 2008-12-22 | 2012-06-14 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 磁気ラベルを使用するトロポニンiに関するアッセイ |
| CN103975241B (zh) * | 2011-08-03 | 2016-01-20 | 奎德尔公司 | 用于提高a型链球菌免疫测定法的特异性的n-乙酰基-d-葡糖胺 |
| EP2843412B1 (en) | 2012-04-27 | 2018-01-03 | Konica Minolta, Inc. | Antigen detection method which uses lectin and comprises enzyme treatment step |
| US9874558B2 (en) | 2012-12-28 | 2018-01-23 | Konica Minolt, Inc. | Immunoassay method less affected by impurities |
| US10371704B2 (en) | 2013-12-27 | 2019-08-06 | Konica Minolta, Inc. | Method for discriminating between prostate cancer and a benign prostate disease |
| JP6323463B2 (ja) | 2013-12-27 | 2018-05-16 | コニカミノルタ株式会社 | 診断用情報の分析方法およびそのためのキット |
| EP3159694B1 (en) | 2014-06-20 | 2019-10-23 | Konica Minolta, Inc. | Sandwich assay using labeled lectin and kit therefor |
| JP6651794B2 (ja) * | 2015-11-05 | 2020-02-19 | 富士レビオ株式会社 | 心筋トロポニンi測定試薬及び方法 |
| JP6668459B2 (ja) * | 2016-04-13 | 2020-03-18 | 株式会社Lsiメディエンス | 硫酸化多糖類を用いた免疫学的測定法 |
| ES3071649T3 (en) * | 2017-01-27 | 2026-06-24 | Hoffmann La Roche | Methods for modulating signal intensity in interaction assays |
| EP3593122A4 (en) * | 2017-03-07 | 2021-01-06 | Ortho-Clinical Diagnostics, Inc. | METHOD OF DETECTION OF ANALYTES |
| JPWO2018174044A1 (ja) * | 2017-03-22 | 2020-01-23 | 富士フイルム和光純薬株式会社 | 糖鎖を有する物質とレクチンとの複合体形成方法 |
| JP2024501434A (ja) * | 2020-12-03 | 2024-01-12 | オルト-クリニカル ダイアグノスティックス インコーポレイテッド | 遮断剤としてのヘパリンリチウム |
| WO2022212714A1 (en) | 2021-04-01 | 2022-10-06 | Becton Dickinson And Company | Methods for enhancing specificity and sensitivity of group a streptococcus immunoassay |
| CN113671195A (zh) * | 2021-09-13 | 2021-11-19 | 迈克生物股份有限公司 | 抗双链dna抗体检测试剂盒及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH02238361A (ja) | 1989-03-10 | 1990-09-20 | Sekisui Chem Co Ltd | 免疫反応測定法および免疫反応測定用試薬 |
| DE3922873A1 (de) * | 1989-04-25 | 1990-10-31 | Boehringer Mannheim Gmbh | Spezifische antikoerper gegen troponin t, ihre herstellung und verwendung in einem reagenz zur bestimmung von hermuskelnekrosen |
| US5529985A (en) * | 1990-04-23 | 1996-06-25 | Akzo Nobel Nv | Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type |
| ES2136090T3 (es) | 1991-05-30 | 1999-11-16 | Abbott Lab | Reactivos que contienen un inhibidor de fijacion no especifico para analisis de fijacion con captura de iones. |
| FR2718849B1 (fr) * | 1994-04-14 | 1996-06-14 | Pasteur Sanofi Diagnostics | Procédé d'immunodosage de l'antithrombine III activée par un glycosaminoglycane, anticorps monoclonaux correspondants et leur procédé d'obtention. |
| JP2649016B2 (ja) | 1994-07-15 | 1997-09-03 | 三洋化成工業株式会社 | 免疫反応干渉作用の除去方法 |
| WO1996010076A1 (en) | 1994-09-28 | 1996-04-04 | Spectral Diagnostics Inc. | A monoclonal antibody to human cardiac troponin i |
| US5639626A (en) * | 1994-11-15 | 1997-06-17 | Chiron Diagnostics Corporation | Reagents for specific binding assays |
| US6991907B1 (en) * | 1995-04-18 | 2006-01-31 | Biosite, Inc. | Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays |
| US6627404B1 (en) * | 1995-04-18 | 2003-09-30 | Biosite, Inc. | Methods for improving the recovery of troponin I and T in membranes, filters and vessels |
| US5616460A (en) * | 1995-06-07 | 1997-04-01 | Abbott Laboratories | Buffer composition for reagents for immunoassay |
| RU2122736C1 (ru) * | 1996-01-31 | 1998-11-27 | Научно-технический центр "Лекбиотех" | Набор для выявления сенсибилизирующих аллергенов методом твердофазного иммуноферментного анализа |
| US5922690A (en) * | 1996-04-25 | 1999-07-13 | Van Gorp; Cornelius L. | Dermatan disulfate, an inhibitor of thrombin generation and activation |
| JP2000065837A (ja) * | 1998-08-24 | 2000-03-03 | Seikagaku Kogyo Co Ltd | グリコサミノグリカン又はグリコサミノグリカン結合性分子の測定方法及びその測定用キット |
| CA2348781A1 (en) * | 1998-11-12 | 2000-05-25 | Novolytics Inc. | Compositions and methods for producing vascular occlusion |
| JP4454885B2 (ja) | 2001-05-21 | 2010-04-21 | アルフレッサファーマ株式会社 | 免疫測定方法およびそのための試薬 |
| AU2004230592B2 (en) | 2003-04-14 | 2007-10-04 | Caliper Life Sciences, Inc. | Reduction of migration shift assay interference |
| US7172906B2 (en) * | 2004-11-16 | 2007-02-06 | Dade Behring Inc. | Reduction of non-specific binding in assays |
| ES2544236T3 (es) * | 2005-11-17 | 2015-08-28 | Siemens Healthcare Diagnostics Inc. | Reducción de unión no específica en ensayos |
-
2007
- 2007-08-28 US US11/846,390 patent/US8617820B2/en active Active
-
2008
- 2008-08-21 AU AU2008207454A patent/AU2008207454B2/en not_active Ceased
- 2008-08-27 AR ARP080103711A patent/AR068043A1/es unknown
- 2008-08-27 CA CA2639196A patent/CA2639196C/en not_active Expired - Fee Related
- 2008-08-27 RU RU2008135060/15A patent/RU2490648C2/ru not_active IP Right Cessation
- 2008-08-27 CL CL2008002525A patent/CL2008002525A1/es unknown
- 2008-08-27 JP JP2008217651A patent/JP5274934B2/ja active Active
- 2008-08-28 KR KR1020080084488A patent/KR101557034B1/ko not_active Expired - Fee Related
- 2008-08-28 EP EP08252839.9A patent/EP2031392B1/en active Active
- 2008-08-28 CN CN200810213696.0A patent/CN101377488B/zh not_active Expired - Fee Related
- 2008-08-28 BR BRPI0803650-0A patent/BRPI0803650A2/pt not_active IP Right Cessation
- 2008-08-28 ES ES08252839.9T patent/ES2525330T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ES2525330T3 (es) | 2014-12-22 |
| CN101377488A (zh) | 2009-03-04 |
| EP2031392A1 (en) | 2009-03-04 |
| AU2008207454B2 (en) | 2015-03-26 |
| CN101377488B (zh) | 2015-04-01 |
| JP2009053195A (ja) | 2009-03-12 |
| CL2008002525A1 (es) | 2009-01-16 |
| KR20090023223A (ko) | 2009-03-04 |
| US20090061455A1 (en) | 2009-03-05 |
| US8617820B2 (en) | 2013-12-31 |
| RU2008135060A (ru) | 2010-03-10 |
| AR068043A1 (es) | 2009-10-28 |
| HK1130089A1 (en) | 2009-12-18 |
| CA2639196C (en) | 2016-07-19 |
| EP2031392B1 (en) | 2014-09-24 |
| CA2639196A1 (en) | 2009-02-28 |
| AU2008207454A1 (en) | 2009-03-19 |
| JP5274934B2 (ja) | 2013-08-28 |
| RU2490648C2 (ru) | 2013-08-20 |
| KR101557034B1 (ko) | 2015-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR068043A1 (es) | Uso de glicosaminoglicanos para reducir la union inespecifica en inmunoensayos | |
| BRPI0923199B8 (pt) | método para determinar a presença de anticorpos de fixação de complemento | |
| BRPI0906903B8 (pt) | anticorpo monoclonal e método de detecção da expressão de cd70 | |
| EP2538218A8 (en) | Biochemical markers for CVD risk assessment | |
| WO2007035633A3 (en) | Screening assays and methods | |
| WO2008060394A3 (en) | Methods and assays for detecting gp73-specific autoantibodies | |
| WO2008007242A3 (en) | Increased specificity of analyte detection by measurement of bound and unbound labels | |
| BR0114343A (pt) | Ensaio de microdisposição de alérgenos | |
| WO2008106648A3 (en) | Immunoassays exhibiting a reduction in prozone phenomena | |
| BRPI0820885B8 (pt) | "anticorpo ou fraguimento do mesmo, célula de hibridoma, polinucleotídeo, polipeptídeo compreendendoum domínio de cadeia pesada ou leve de anticorpo, método para detecção de gravidez em um animal bovino, kit e método de purificação de um antígeno principal associado à gravidez (pag)". | |
| GB2404022B (en) | Competitive assays for the detection of methamphetamine group drugs | |
| BRPI0915667A2 (pt) | ligante, fragmentos scfv e fab, anticorpo, composição farmacêutica, ácido nucleico, molécula de ácido nucleico, vetor, célula hospedeira, método para produção do ligante, método de tratamento, antiligante, método de detecção do antiligante em uma amostra biológica, kit de imunoesaio para detecção do antiligante, uso do kit de imunoensaio | |
| WO2010096674A3 (en) | A+ biomarker assays | |
| BR112012031860A8 (pt) | Método para detecção de um alvo biológico em um ensaio de afinidade, disposição de detecção para um alvo biológico e porção de captura para uso em um método | |
| EP1183390B8 (en) | METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY | |
| WO2007149809A3 (en) | Tacrolimus standard and methods of using same | |
| DE602006010242D1 (de) | Immunoassay mit doppelter standardkurve | |
| BRPI0614151A2 (pt) | métodos para determinar quais os membros, individualmente ou em combinação, de um conjunto elementar de testes intermediários são preditivos de um conjunto elementar de resultados de teste de uso final, para prever se uma amostra candidato atenderá ao conjunto elementar de resultados de teste de uso final, para prever se uma amostra de lubrificante candidato será aprovada em um teste de uso final escolhido para lubrificantes, para determinar qual a combinação de membros de um conjunto elementar de testes intermediários que tem uma correlação elevada com um conjunto elementar de resultados de teste de uso final e para escolher componentes e quantidades de componentes em lubrificantes, fluidos funcionais ou graxas | |
| WO2006088700A3 (en) | Human ring specific bnp antibodies | |
| MX2020010714A (es) | Metodos para cuantificar la il-33. | |
| BR112022020949A2 (pt) | Imunoensaio de diminuição de fluorescência | |
| WO2008057767A3 (en) | Reduction of non-specific binding in immunoassays | |
| BRPI0606529A2 (pt) | método para a detecção da presença de um prìon patogênico em uma amostra e controle e substituto para uso em um ensaio de detecção de prìon | |
| BR112016012560A2 (pt) | Método para determinar a quantidade de um analito em uma amostra e dispositivo analítico automático | |
| ES2161011T3 (es) | Reactivos para ensayo de ion diazonio y metodos para su utilizacion. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B03A | Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: REF. A RPI NO 2155 DE 24/04/2012. ANULACAO DA EXIGENCIA 6.6 POR TER SIDO INDEVIDA. REQUERENTE NAO APRESENTOU RESPOSTA A EXIGENCIA CONFORME DISPOE A RESOLUCAO 207 DE 24/04/2009, ENTRETANTO, A RESPOSTA CONSTA NO FORMULARIO DE DEPOSITO. |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 7.4 NA RPI NO 2440 DE 10/10/2017 POR TER SIDO INDEVIDA. |
|
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2529 DE 25-06-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |